Embolic Protection Devices Market Information: By type (Distal Filter Devices, Proximal Occlusion Devices), Material (Nitinol), Usage (Disposable Devices), Application (Cardiovascular Diseases), End-User (Hospitals & Clinics) - Global Forecast Till 2030

Embolic Protection Devices Market Overview

The Embolic Protection Devices Market is expected to reach USD 558.03 Million by 2030 at 8.40% CAGR during the forecast period 2022-2030. An embolism is a particle that causes a blockage on the inside of a blood artery. It can take the form of a blood clot, a fat globule, or an air bubble. An embolism can occur after surgery as a result of any damage to the walls, resulting in the production of clots in that area. The removal of these plaques and debris is critical. The embolism prevention devices catch and retrieve lipid-rich plaque, which are friable constituents discharged following percutaneous interventional operations before they lodge in the distal microcirculation.

The increased frequency of cardiovascular disorders, increasing technologically advanced devices, increasing desire for minimally invasive procedures, and increasing market penetration are all driving factors in the embolic protection devices market. Furthermore, the embolic protection devices market is expected to be driven by factors such as rising approval for embolic protection devices, government initiatives and assistance, and expanding payment coverage for cardiologic anomalies.

Key Players  

Some of the key players in the Embolic Protection Devices market are Medtronic, Abbott, Boston Scientific, Cordis, Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.

Intended Audience

• Pharmaceutical Manufacturers and Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Market Segmentation   

The embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user. Considering type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices. By material, the market is segmented into nitinol and polyurethane. By usage, the market is segmented into disposable devices and reusable devices. With reference to application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. Furthermore, on cardiovascular diseases, the market is segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft disease. On account of end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas region is segmented into North America and South America. Further, North America is segmented into two major countries, namely, the U.S. and Canada.

Regional Market Summary

The increasing prevalence of cardiovascular diseases and neurovascular disorders are likely to enhance the growth of embolic protection devices. Additionally, factors such as the increasing demand for minimally invasive procedures, increasing government support, and the increasing demand for technologically advanced treatments are likely to enhance the growth of the embolic protection devices market in North America. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S. This growing rate in cardiovascular disorders is expected to have a direct effect on embolic protection devices as they find application majority in cardiovascular procedures.  Additionally, the increasing healthcare expenditure is likely to propel the growth of the market in the U.S. region.

Europe is the second largest market and holds a healthy share in the global embolic protection devices market. The European market is expected to grow at a strong growth rate during the forecast period owing to the availability of advanced treatment facilities and healthcare expenditure along with the growing need for better healthcare infrastructure. Furthermore, the increasing cardiovascular rate, along with the population inclined towards the sedentary lifestyle is driving the growth of the embolic protection devices market. According to the European Heart Network, in 2015, there were 11.3 million cardiovascular disorder cases in Europe. These increasing occurrences of cardiovascular disorders are expected to have a positive impact on the embolic protection devices market due to their wide usage in cardiac-related disorders. These impacts are likely to enhance the embolic protection devices market in Europe.

Asia Pacific is expected to be the fastest growing market. Factors such as the increasing prevalence of chronic diseases are the major drivers for the market growth. China is expected to be the fastest growing country due to increasing population and raising awareness about the health and availability of new treatment methods. Moreover, the increasing healthcare expenditure and improvement in the standard of living are driving the growth of the embolic protection devices market in the Asia Pacific region. For instance, the New South Wales (NSW) Government is expected to fund over USD 8 million for the development of medical devices during 2018 to 2019. This funding will help to encourage and support investments in the development and commercialization of medical devices and related technologies in New South Wales (NSW). This investment for the development of medical devices is also likely to push the growth of the embolic protection devices market in the Asia Pacific region.

Contego Medical recently announced that its Neuroguard IEP 3-in-1 carotid stent system and post-dilation balloon system with integrated embolic protection achieved CE mark approval. A nitinol stent, a pre-positioned post-dilation balloon, and a microembolic filter with 40 m pores are included in the system. It comes with a closed-cell stent that is optimized for radial strength, vascular coverage, and flexibility. During a procedure, it also features an inbuilt filter that captures both macro-and micro-emboli.

The WIRION system is being recalled by Cardiovascular Systems Inc. due to reports of filter breaking during retrieval. The filter assembly may become difficult to remove in certain circumstances, such as when the filter basket is overflowing. Withdrawal in this case may cause the WIRION system filter component to rip or detach, potentially leading to embolizationExternal Link Disclaimer, the need for additional medical treatments, or even death.

Global Embolic Protection Devices Market Share (%), by Region, 2017

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis

Market Segmentation 

Embolic Protection Device Market, by Type

• Distal Filter Devices


• Distal Occlusion Devices


• Proximal Occlusion Devices


• Embolic Protection Device Market, by Material


• Nitinol


• Polyurethane


• Embolic Protection Device Market, by Usage


• Disposable devices


• Re-usable devices


• Embolic Protection Device Market, by Application


• Cardiovascular Diseases


• Coronary Artery Diseases


• Trans Cather Aortic Valve Replacement


• Saphenous Vein Graft Disease


• Neurovascular Diseases


• Peripheral Vascular Diseases

 Embolic Protection Device Market, by End-User

• Hospitals & Clinics


• Ambulatory Surgical Centers


• Specialty Centers

Embolic Protection Devices Market, by Region

• Americas




• North America




• US


• Canada




• Latin America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• The Middle East & Africa




• Middle East


• Africa

Research Methodology:

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis